PREVENTION OF HBV INFECTION

Three main strategies are available for the prevention of HBV infection:

(1) Behavior modification to prevent disease transmission,

(2) Passiveimmunoprophylaxis, and

(3) Active immunization.

Behavior Modification

Changes in sexual practice and improved screening measures of blood products have reduced the risk of transfusion-associated hepatitis. Behavior modification is thought be more beneficial in developed countries than in developing countries, where neonates and children in early childhood are at the greatest risk of acquiring infection.

Passive Immunoprophylaxis

Hepatitis B Immune Globulin (HBIG) is a sterile solution of ready-made antibodies against hepatitis B. HBIG is prepared from human blood from selected donors who already have a high level of antibodies to hepatitis B and used in passive immunoprophylaxis. Passive immunoprophylaxis is used in four situations.

(1) Newborns of mothers infected with hepatitis B;

(2) After needlestick exposure,

(3) After sexual exposure,

(4) After liver transplantation.

Active Immunization

Prevention of primary infection by vaccination is an important strategy to decrease the risk of chronic HBV infection and its subsequent complications. The first-generation hepatitis B vaccine, an inactive plasma-derived vaccine, became available in 1982. Consequently, the second generation of HB vaccine, a DNA recombinant HB vaccine was also available for general use in 1986. Both of the vaccines were proven to be safe and efficacious in preventing HBV infection. In 1991, the World Health Organization (WHO) recommended that hepatitis B vaccination should be included in national immunization system in all countries with a hepatitis B carrier prevalence (HBsAg) of 8% or greater by 1995 and in all countries by 1997. By May 2002, 154 countries had routine infant immunization with hepatitis B vaccine

 

CORPORATE ADDRESS

Beacon Pharmaceuticals Limited
9/A,Toyenbee Circular Road,
Motijheel,Dhaka-1223, Bangladesh.
Phone: +880-2-57165371-79
Fax: +880 2-57165380
Web: beaconpharma.com.bd

ALTERNATIVE CONTACT 1

Skype ID: shahariar_tamal
WhatsApp: +8801922121404
WeChat: +8801922121404
IMO: +8801922121404
Viber: +8801922121404
Email: tamal-tsd@beaconpharma.com.bd
beaconbdd@gmail.com

ALTERNATIVE CONTACT 2

Skype ID: masfikur.rahman
WhatsApp: +8801730026182
IMO: +8801730026182
Viber: +8801730026182
Email: masfik@beaconpharma.com.bd